0.5123USD-3.03%Mkt Cap: 3.12M USDP/E: 53.28Last update: 2026-06-01
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular dis…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap3.12M USD
Enterprise Value2.17M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.72M USD
Revenue/Share—
Last Price0.5123 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)53.28
P/E (Forward)—
PEG—
EV/EBITDA-0.20
EV/Revenue—
P/S—
P/B0.47
EPS (TTM)0.01
EPS (Forward)—
52W Range
0.50000% of range6.200
52W High6.200 USD
52W Low0.5000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-519.94%
ROA-111.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.48M USD
CapEx (TTM)3.06M USD
FCF Margin—
FCF Yield23.77%
Net Debt-875.93K USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.10
Current Ratio0.30
Quick Ratio0.13
Book Value/Sh1.128 USD
Cash/Share0.1860 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 16, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.85M
Float5.82M
Insiders0.90%
Institutions3.68%
Short Interest
Short Ratio0.2d
Short % Float7.64%
Short % Out.7.54%
Shares Short441.25K
Short (prev mo.)71.19K
Technical
SMA 500.7799 (-34.3%)
SMA 2002.007 (-74.5%)
Beta1.41
S&P 52W Chg27.70%
Avg Vol (30d)1.67M
Avg Vol (10d)354.04K
Technical Indicators
RSI (14)36.5
MACD-0.0842
MACD Signal-0.0771
MACD Hist.-0.0071
BB Upper0.8211 USD
BB Middle0.6522 USD
BB Lower0.4834 USD
BB Width51.77%
ATR (14)0.0930 USD
Vol Ratio (20d)0.10x